#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phenylketonuria Giant cell tumour of tendon sheath Chorioretinitis HER2 gene amplification Glomerulonephritis rapidly progressive Leiomyosarcoma Cataract Staphylococcal infection Anaplastic large cell lymphoma T- and null-cell types Gastric cancer Epstein-Barr virus infection Extra-osseous Ewing's sarcoma Proteus syndrome Diffuse large B-cell lymphoma recurrent Gastrointestinal stromal tumour More trials…

    Learn about Rare Diseases

    Rett syndrome – Diagnostics Factor IX deficiency – Diagnostics Small intestine leiomyosarcoma – Basic Information Marfan’s syndrome – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Diagnostics Bronchopulmonary dysplasia Ehlers-Danlos syndrome Alagille syndrome – Trials in Disease Antisynthetase syndrome Chondrosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Lactate Bms-986458 Afimetoran Besilate Dihydrate MRNA-1345 Urea Mbf-118 Linvoseltamab Ponsegromab Human Coagulation Factor Ix Alirocumab Amy109 Methotrexate Sodium Gfh925 Bosentan AZD5335 Azd5492 Rbd5044 Sodium NORETHISTERONE ACETATE Imsidolimab Etamsylate More therapies…

    Learn about Your Condition

    Tympanic membrane perforation Hereditary optic atrophy Psychological trauma Pulmonary vascular disorder Cataract Breast angiosarcoma Leukoencephalopathy Endometriosis Small fibre neuropathy Mitochondrial DNA depletion Growth hormone deficiency Cardiogenic shock Oesophageal atresia Fibrosarcoma Obstructive pancreatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Avelumab with Chemotherapy for Patients with Resectable Stomach or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    • Gastric cancer
    Investigated Drugs:
    • Avelumab
    • Calcium Folinate
    • Docetaxel
    Spain

  • Study on the Effects of Dornase Alfa for Patients with Subarachnoid Hemorrhage to Improve Independence After 6 Months

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aneurysm ruptured
    Investigated Drugs:
    • Dornase Alfa
    France

  • Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Caffeine
    France

  • Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Treg02
    • Valganciclovir Hydrochloride
    • Methylprednisolone Sodium Succinate
    Germany

  • Study on Adding Trastuzumab and Pertuzumab to Treatment for Patients with Resectable HER2 Positive Esophageal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Pertuzumab
    • Trastuzumab
    The Netherlands

  • Study on Obinutuzumab vs. Rituximab for Children with Steroid-Dependent and Frequent Relapsing Nephrotic Syndrome

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Obinutuzumab
    • Rituximab
    France
Previous Page
1 … 399 400 401 402 403 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!